Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 86, Issue 1 , Pages 51-59, January 2012

Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content

  • E.S. Krul

      Affiliations

    • Solae LLC, 4300 Duncan Avenue, St. Louis, MO 63110, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 314 659 3284; fax: +1 314 659 5284.
  • ,
  • S.L. Lemke

      Affiliations

    • Monsanto Company, St. Louis, MO, USA
  • ,
  • R. Mukherjea

      Affiliations

    • Solae LLC, 4300 Duncan Avenue, St. Louis, MO 63110, USA
  • ,
  • M.L. Taylor

      Affiliations

    • Monsanto Company, St. Louis, MO, USA
  • ,
  • D.A. Goldstein

      Affiliations

    • Monsanto Company, St. Louis, MO, USA
  • ,
  • H. Su

      Affiliations

    • Monsanto Company, St. Louis, MO, USA
  • ,
  • P. Liu

      Affiliations

    • Solae LLC, 4300 Duncan Avenue, St. Louis, MO 63110, USA
  • ,
  • A. Lawless

      Affiliations

    • Provident Clinical Research/Biofortis North America, Glen Ellyn, IL, USA
  • ,
  • W.S. Harris

      Affiliations

    • Sanford Research/USD, Sioux Falls, SD, USA
  • ,
  • K.C. Maki

      Affiliations

    • Provident Clinical Research/Biofortis North America, Glen Ellyn, IL, USA

Received 9 August 2011; received in revised form 11 October 2011; accepted 13 October 2011. published online 07 November 2011.

Abstract 

Objective

The purpose of this randomized, controlled, parallel group study was to characterize the relationships between dosages of stearidonic acid (SDA) and eicosapentaenoic acid (EPA), and incorporation of EPA into red blood cell (RBC) membranes over time.

Methods

Healthy subjects (n=131) received capsules with placebo (safflower oil), SDA (0.43, 1.3, 2.6, or 5.2g/d) or EPA (0.44, 1.3, or 2.7g/d) for 12 weeks. RBC fatty acids were analyzed biweekly.

Results

RBC %EPA increased in all EPA and SDA groups (p<0.02 vs. control) except the 0.43g/d SDA group (p=0.187). For theoretical intakes of EPA of 0.25, 0.5, and 0.89g/d, the amounts of SDA needed to achieve equivalent RBC EPA enrichment were 0.61, 1.89, and 5.32g/d (conversion efficiencies of 41%, 26%, and 17%), respectively.

Conclusions

SDA increased RBC %EPA in a dosage and time-dependent manner at intakes as low as 1.3g/d.

Keywords: Omega-3 fatty acids, Eicosapentaenoic acid, Stearidonic acid, RBC, Dosage-response

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This trial was funded by Solae LLC, St. Louis, MO and Monsanto Company.

PII: S0952-3278(11)00147-5

doi:10.1016/j.plefa.2011.10.005

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 86, Issue 1 , Pages 51-59, January 2012